(R)-4-(morpholinomethyl)-N-(1-(4-(3-(pyridin-3-ylmethyl)ureido)phenyl)ethyl)benzamide

ID: ALA4210753

PubChem CID: 145964549

Max Phase: Preclinical

Molecular Formula: C27H31N5O3

Molecular Weight: 473.58

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](NC(=O)c1ccc(CN2CCOCC2)cc1)c1ccc(NC(=O)NCc2cccnc2)cc1

Standard InChI:  InChI=1S/C27H31N5O3/c1-20(30-26(33)24-6-4-21(5-7-24)19-32-13-15-35-16-14-32)23-8-10-25(11-9-23)31-27(34)29-18-22-3-2-12-28-17-22/h2-12,17,20H,13-16,18-19H2,1H3,(H,30,33)(H2,29,31,34)/t20-/m1/s1

Standard InChI Key:  AIZJJNIMVQOUIQ-HXUWFJFHSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   37.7545  -15.5390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7533  -16.3626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4655  -16.7716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.1793  -16.3622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1765  -15.5354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4637  -15.1260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8867  -15.1200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6001  -15.5300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.3104  -15.1147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0238  -15.5247    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.3073  -14.2933    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.7341  -15.1093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4393  -15.5211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1491  -15.1064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1465  -14.2842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4281  -13.8785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7254  -14.2914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8562  -13.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8541  -13.0548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   45.5608  -12.6444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5587  -11.8273    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   46.2696  -13.0512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.2697  -13.8686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.9776  -14.2753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.6853  -13.8648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.6805  -13.0434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.9720  -12.6404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   48.3945  -14.2706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   48.3977  -15.0878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   47.6914  -15.4947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.6927  -16.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   48.4002  -16.7180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   49.1081  -16.3078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   49.1085  -15.4880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5650  -14.2788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 29 34  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 18 35  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4210753

    ---

Associated Targets(Human)

A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COR-L23 (253 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 473.58Molecular Weight (Monoisotopic): 473.2427AlogP: 3.73#Rotatable Bonds: 8
Polar Surface Area: 95.59Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.52CX Basic pKa: 6.66CX LogP: 2.55CX LogD: 2.47
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.46Np Likeness Score: -1.91

References

1. Palacios DS, Meredith E, Kawanami T, Adams C, Chen X, Darsigny V, Geno E, Palermo M, Baird D, Boynton G, Busby SA, George EL, Guy C, Hewett J, Tierney L, Thigale S, Weihofen W, Wang L, White N, Yin M, Argikar UA..  (2018)  Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen.,  28  (3): [PMID:29275937] [10.1016/j.bmcl.2017.12.037]

Source